The prevalence of obesity and overweight among Iranian population: an umbrella systematic review and meta-analysis Authors: Azadeh Dehghani, Roghayeh Molani-Gol, Maryam Mohammadi-Narab, Abdolreza Norouzy, Mohammad Hassan Abolhassani, Seyed Mohammad Tabatabaee Jabali, Abdolreza Pazouki, Fahimeh Soheilipour, Fatemeh Mohammadi-Nasrabadi Published: 2024 ABSTRACT AbstractBackgroundThe present umbrella systematic reviews and meta-analyses aim to determine the comprehensive prevalence of obesity and overweight across different age subgroups in Iran.MethodsWe conducted a comprehensive search across many databases, including Science Direct, Web of Science, Scopus, PubMed, and Google Scholar, to retrieve papers published until November 2023. The meta-analyses included in this study examined the prevalence of obesity and overweight in Iran. The current umbrella meta-analysis finally contained 24 meta-analyses. We evaluated the scientific reliability of the studies using the Assessment of Multiple Systematic Reviews (AMSTAR2).ResultsThe overall prevalence of overweight and obesity among the Iranian population was 18.38% (95% CI: 10.267, 26.496) and 10.91% (95% CI: 9.654, 12.177), respectively. The overall obesity prevalence in males was 9.93 (95%CI: 8.483, 11.388), and in females was 9.67% (95%CI: 8.317, 11.033). The prevalence of overweight and obesity among children and adolescents was 12.43% (95% CI: 10.184, 14.683) and 6.51% (95% CI: 5.866, 7.157), and in adults, it was 27.39% (95% CI: 14.878, 39.914) and 17.20% (95% CI: 13.483, 20.919), respectively. Male children and adolescents had a higher prevalence of overweight and obesity than females, but adult males had a lower prevalence than females.ConclusionThis study presents the trend of obesity and overweight among the Iranian population. Since the trend of increasing overweight and obesity is alarming, policymakers and healthcare providers at the national and regional levels should design and implement preventive programs and interventions.Supplementary InformationThe online version contains supplementary material available at 10.1186/s12889-024-20860-8.Keywords: Prevalence, Obesity, Overweight, Population, Iran Introduction High body mass index (BMI) is now widely recognized as a global epidemic, and its growing impact is a major health concern in both industrialized and developing countries [1, 2]. According to research, obesity is the most serious of the four major global risk factors that are considered public health problems [3]. “Globesity” refers to the worldwide increase in obesity rates [4]. In fact, obesity stands out as the most significant nutrition-related disorder and the most important public health issue characterized by the accumulation of excessive and abnormal values of body fat, leading to adverse health outcomes [5]. Obesity is associated with chronic and life-threatening medical disorders, including metabolic diseases, cardiovascular disease (CVDs), osteoarthritis, sleep apnea, Alzheimer’s disease, depression, and certain types of cancer and their comorbidities [6]. Concurrently with the increasing prevalence of obesity among adults, there is also a worrisome surge in obesity rates in children. This tendency presents a substantial threat to the well-being of the younger generation and has ramifications for the future of nations, especially in developing countries [7]. A multitude of factors can contribute to obesity. These include hormonal, genetic, and metabolic factors such as leptin, as well as socio-economic factors, dietary habits, particularly the consumption of excessive calories and unhealthy carbohydrates. Moreover, a sedentary lifestyle, urbanization, and industrialization of societies can also play significant roles [8]. Obesity not only has detrimental effects on people’s health but also imposes a financial burden on individuals and society. According to a report published in 2023 by the World Obesity Federation, if prevention and treatment efforts fail to improve, it could lead to an economic impact totaling US$4.32 trillion by 2035, representing nearly 3% of global GDP [9]. Furthermore, obesity causes 3256.0 disability-adjusted life years (DALYs) and 109.5 age-standardized deaths per 100,000 people [10]. An analysis of global statistics revealed a rise in the occurrence of obesity and overweight among children and adolescents. Nevertheless, in recent years, this trend has either steadied or begun to decline in certain nations [11]. Among six regions—Africa, the Americas, the Eastern Mediterranean, Europe, Southeast Asia, and the Western Pacific—the highest obesity rates are observed in the Americas and Europe. In the Americas, obesity prevalence surged from 6.8% in 1980 to 22.4% in 2019, while in Europe, it rose from 8.4% to 20% during the same period. In the Eastern Mediterranean, obesity increased from 6.4% to 17.4%, and in Africa, from 3.8% to 10.9%. The West Pacific, with the lowest initial obesity prevalence at 0.9% in 1980, saw a fivefold increase to 5% by 2019. Similarly, the Southeast Asian region, starting at 0.9% in 1980, experienced a larger jump to 7.9% by 2019 [12]. In Iran, a developing country in the Middle East, the estimated prevalence of obesity stands at 20.1% [13]. Indeed, determining the prevalence of obesity is a fundamental component of effectively planning healthcare strategies and policies to address this issue and its associated comorbidities [14]. Systematic reviews and meta-analyses have recently been published on the prevalence of obesity in the Iranian population across different age groups [7, 13, 15]. To the best of our knowledge, there is currently a lack of epidemiological studies providing an overall comprehensive prevalence among different age subgroups. Therefore, the aim of the present umbrella systematic reviews and meta-analyses is to ascertain the extensive prevalence of obesity and overweight across various age subgroups. Materials and methods Search strategy and data sources The present study utilized the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) format in conducting a comprehensive umbrella systematic review and meta-analysis [16] (Supplementary Table 1). This study was approved by Research Vice Chancellery of Iran University of Medical Sciences, Tehran, Iran (Ethics Code: IR.IUMS.REC.1402.769). PubMed, Scopus, Google Scholar, Science Direct, and Web of Science search engines were searched for all systematic reviews and meta-analyses of obesity and overweight in Iran published until November 2023. The following search terms were used in this study: obesity OR overweight OR “body mass index” OR weight OR BMI OR obes* AND prevalence OR epidemiology OR state OR health status AND Iran OR Persia OR Iranian OR Persian. Two authors independently conducted the literature search, and any discrepancies were resolved through consensus. Additionally, a manual search was conducted to identify additional eligible studies by examining the “cited by,” “related articles,” and reference lists of the included studies. Supplementary Table 2 describes the search strategy. Supplementary Table 3 show the overlap between primary studies across included meta-analyses. Study screening and selection The PICO criteria will be utilized to establish the keywords and evaluate the articles acquired from databases (Table 1). It is characterized as CoCoPop, which incorporates the investigated Condition, studied Context, and studied Population for the current prevalence study [17]. The search was conducted without any limitations or restrictions throughout the whole publishing time. The present analysis considered all English and Farsi publications conducted in Iran until 2023 as eligible for inclusion. To gain insight into the current obesity and overweight situation in the country, no time limit or other exclusion criteria was applied. The inclusion criteria included each meta-analysis reporting obesity and overweight prevalence in children, adolescents, and adults in Iran with effect sizes (ES) and 95% confidence intervals (95% CIs). Screening of all publications based on eligibility criteria was performed independently by two authors (AD and RMG). In the first step, all titles and abstracts entered in Endnote were screened. A standard form was created in an Excel spreadsheet to extract and enter data from the included studies efficiently. The following data were extracted: first author, year of publication, study population, number of participants, gender, number of studies included in the meta-analysis, study type, criteria for overweight and obesity, effect size, and 95% CIs. Table 1PICOS criteria for inclusion of studiesParameterInclusion criteriaConditionOverweight, ObesityContextIranPopulationChildren and adolescents- adultsStudy designSystematic ReviewMeta-analysisPublished in English and Farsi dated up to November 2023 PICOS criteria for inclusion of studies Systematic Review Meta-analysis Published in English and Farsi dated up to November 2023 Quality assessment We evaluated each included study using the Assessment of Multiple Systematic Reviews (AMSTAR2) [18] method. This 16-question validated tool assesses each study’s pooling process and findings. Each question has four options: yes, partial yes, no, and no meta-analysis. The total score is then calculated, and each study is rated as high, moderate, low, or very poor quality. The GRADE approach [19] was used to assess the study’s strength and overall quality in accordance with Cochrane criteria. The GRADE technique evaluates five risk factors: bias, consistency, directness, accuracy, and publication bias. Finally, the quality is rated. The quality level will decrease if any of the aforementioned risk factors are disregarded. Furthermore, we classified evidence of outcomes into four categories according to the Credibility Assessment criteria: class I (convincing evidence), class II (highly suggestive evidence), class III (suggestive evidence), class IV (weak evidence), and NS (non-significant) [20, 21]. Data synthesis The current study employed random effects models using restricted maximum likelihood approaches to assess the combined ES and 95% CI. Also, heterogeneity was detected through the I2 statistic and the Cochrane’s Q test. Significant heterogeneity among studies was defined by I2 > 50% or p < 0.1 for the Q test [22]. In order to identify the sources of variation, we conducted a subgroup analysis based on the number of studies, including the year in which the data was collected and the gender of the participants. Sensitivity analysis was employed to determine the impact of removing a particular study on the overall effect size (ES). Formal Egger’s and Begg’s tests, together with visual inspection of funnel plots, were employed to evaluate the influence of studies with a minimum of 10 studies or fewer than 10 studies, respectively [23–25]. The “trim-and-fill” method was utilized in this work to quantify the asymmetries resulting from the small study effect precisely. A P-value below 0.05 was deemed significant. STATA software version 17.0 (Stata Corporation, College Station, TX, USA) was used to perform all statistical analyses. Results Literature search Initially, 384 articles were obtained by searching the electronic databases [Scopus (n = 174), Web of Sciences (n = 103), PubMed (n = 47), and Google Scholar (n = 60)]. In the second step, 98 duplicate articles were removed, and two independent authors screened the title and abstracts of the remaining 286 articles. Among those, the full text of 35 articles was evaluated, and 11 articles were removed because they lacked the required information to be included in the analysis. Finally, 24 meta-analyses were included in the current umbrella meta-analysis [7, 8, 13, 15, 26–45]. Figure 1 indicates the PRISMA flow diagram of screening and selection of the studies. Flow chart of study selection for inclusion studies in the umbrella review Study characteristics The features of the eligible articles for the current meta-analysis are shown in Table 2. All the included research was published between 2009 and 2023. The number of primary studies involved in the included meta-analysis ranged from 6 to 193. The number of participants in the included studies ranged from 4,434 to 3,845,768. A total of 15,074,657 subjects of different age groups were involved in this study. Overweight and obesity were defined based on BMI for adults and International Obesity Task Force (IOTF), Centers for Disease Control and Prevention (CDC), and World Health Organization (WHO) criteria for children and adolescents. Table 2Characteristics of the included studies in Umbrella Systematic Review and Meta-Analysis of Obesity and Overweight Prevalence in Iranian Children and AdolescentsFirst author/ Year of publication (reference no.)Number of primary studies; type of reviewCountry of the studyTime of data collectionSample size (M/F)Age of participants (year)CriteriaFindings (Prevalence of overweight, obesity, both)1Mirzazadeh et al., 2009 [26]58January 1997 and December 2007132,864(> 18 yr.), (< 18y)adults and childrenBMI > 30BMI > P95NCHS(BMI calculated by weight (kg)/height2 (m); P95; NCHS)The overall prevalence of obesity for adults (> 18 yr) and children (< 18y) was 21.5% (CI 95% 17.4–25.6) and 5.5% (CI 95% 4.5–6.4), respectivelyThe prevalence of obesity in boys and girls (< 18y) was 5.3% (CI 95% 4.1–6.4) and 4.8% (CI 95% 4.0–5.7), respectivelyIt increased in both adult men and women to 13.7% (CI 95% 10.9–16.7) and 27.3% (CI 95% 21.3–33.4), respectively2Ng et al., 2013 [27]-1980- 2013NMadolescents and children < 20 > 20BMIThe prevalence of obesity in boys (< 20y) (> 20y) was 5·9 (CI 95%4.8–7.2) (and13.6(CI 95%12.5–14.8)), respectively. The prevalence of obesity and overweight in girls (< 20y) (> 20y) was 7.2 (CI 95% 5.7–8.9) (and 29.3 (CI 95% 27.2–31.6)), respectively3Mirzazadeh et al., 2013 [28]32January 1990 to December 2007209,166aged 14—81 yearsAdolescents and adultsBMI > 30The overall prevalence of obesity in adults was 18.5% (95% CI: 15.1–21.8), respectively. The prevalence of obesity in men and women was 12.9% (95% CI: 10.9–14.9) and 26.2% (95% CI: 21.3–30.5), respectively4Jafari-Adli et al., 2014 [8]193Jan 2005 up to Jan 2014NM > 18 and adultsCDC, WHO, and IOTF for children aged 5 or younger that includeBMI-for-age growth charts defines obesity and overweight as > 95th, and 85-95th percentile of body mass index, respectively. The NCHS/WHO cut-off percentile classification for age includes:underweight < 5th BMI-for-age; normal weight5th < BMI-for-age < 85th; overweight 85th BMI-for-age < 95th; and obese BMI-for-age > 95th. The same percentiles cut-offs were considered for the CDC as well. IOTF used data from six national studies carried out in different countries to provide percentile curves that passed through the widely used cut-off points of 25 kg/m2 and30 kg/m2 for adults overweight and obesityThe range of overweight and obesity prevalence in national studies in adults, was 27.0–38.5 (95% CI: 26.8–27.1, 37.2–39.8), and 12.6–25.9 (95% CI: 12.2–13.0, 24.9–26.8), separately. In < 18 the range of overweight and obesity prevalence in national studies was 5.0–13.5 (95% CI: 4.5–5.5, 13.4–13.6), and 3.2–11.9 (95% CI:3.0–3.4, 11.3–12.4)5Kelishadi et al., 2014 [29]107October 2007 and August 20123,746,869children and adolescents ages 2 to 18 y were included, with the interquartile range of sample sizes of 415 to 2076U.S. CDC in 2000 (i.e., 85th percentile BMI _ 94th percentile was regarded as overweight and BMI _ 95th percentile as obese);WHO (i.e., BMI _ 2 z score was regarded as overweight andBMI _ 3 z score as obese); or IOTF (i.e., percentile curves that correspond to cutoff points of 25 kg/m2 and 30 kg/m2 for adult overweight and obesity, respectively)the overall prevalence of obesity and overweight remained relatively constant in the 2000s and are estimated to be about 5.1% (95% confidence interval [CI], 4.4–5.8) and 10.8% (95% CI, 10.2–11.4), respectively6Rahmani et al., 2014 [30]144between 1990 and2011377,858 > 18 < 18the WHO, was defined as BMI ≥ 30 for adultpopulations (at least 18 years of age). For people < 18, most articles used the criteria of the CDC 2000 and IOTF which defined obesity according to the BMI ≥ percentile 95th of the BMI in the respective populationThe prevalence of obesity in populations > 18 was estimated as 21.7% (CI 95%: 18.5%—25%) and in populations < 18 as 6.1% (CI 95%: 6.8%-5.4%). Meta-regression analysis showed an ascending trend in the prevalence of obesity in Iran. The prevalence rates of obesity according to the BMI index, NCHC and percentile > 95 were 17.4%, 7.6% and 7.4%, respectively. The BMI mean was 19.3 in populations < 18 (CI 95%: 17–21.6) and 25.2 in those > 18 (CI 95%: 27.1–23.3)7Ghanbari et al., 2016 [31]75up to December 30, 2015155,839children and adolescents up to 20 years old, children < 6 years, between 6 and 12 years, and 12–20 years oldThe different reference values currently used as the standards to assess children’s obesity and overweight, the CDC reference uses BMI percentiles for ages 2–20 years, Overweight: BMI < 85th and < 95th percentile and obese: BMI < 95th percentile. WHO Child Growth Standards (birth to age 5), obese: BMI > 3 standard deviations above the WHO growth standard median and overweight: BMI > 2 standard deviations above the WHO growth standard median. WHO Reference 2007 (ages 5–19), obese: BMI > 2 standard deviations above the WHO growth standard median and overweight: BMI > 1 standard deviation above the WHO growth standard median. The reference values include age- and sex-specific data from the first NHANES I collected in 1971–74 in the United States. [4, 9, 11] The Childhood Obesity Working Group of the IOTF provides international BMI cut points by age and sex for overweight and obesity for children aged 2–18 reference uses sex- and age-specific BMI cutoffs that correspond to BMI 25 kg/m2 for overweight and 30 kg/m2 for obesityThe overall prevalence of overweight and obesity in < 6 years was 15.1 (0.145–0.158) and 5.4 (0.051- .058), in 6–12 years was 4.6 (0.044–0.047) and 3.9 (0.038–0.041), in 12–20 years was 9.1 (0.088–0.094) and 4.2 (0.040–0.044), respectively8Fallahzadeh et al., 2017 [32]1512000–2013 > 18 years and < 18 yearsCDCBMI > P95IOTFthe prevalence of obesity was 8.5% (95% confidence interval [CI], 7.9%-9%)overall, 5.5% (95% CI, 5.1%-6.0%) among < 18 years and 15.1% (95% CI, 13.8%-16.5%) among adult also the prevalence of overweight was 17.5% (95% confidence interval [CI], 15.9%-19.1%) overall, 15.1%(95% CI, 13.5%—17%) among < 18 years and 22.6% (95% CI, 19.5%—26.1%) among adult9Khazaei et al., 2017 [33]25Up to Aaugust 201543,413Primary school studentsCDCBMI > P95IOTFHosseini’s Iranian children’s referenceAll 25 papers had the inclusion criteria for the study. Studies showed that the prevalence of obesity in Iranian primary school students was 7.18 percent (95% CI: 5.63 -8.73). The prevalence of obesity was higher in boys than girls (8.02% vs. 6.07%)10Khazaei et al., 2017 [34]51January 1, 1998 to April 1, 201547,893school-aged children and youth aged 6–18 yearsCDCIOTFHosseini’s Iranian children’s referenceThe prevalence of obesity was equal to 5.82% [95% confidence interval (CI): 5–6.66] in Iranian students. The prevalence of obesity was higher in boys than in girls (6.85% compared to 5.13%) (P = 0.300). The highest prevalence of obesity was related to students living in the North and Northwest areas with 7.07% (95% CI: 4.35–9.78)11Mohammadi et al., 2018 [35]102001–20174,434Iranian female university students15–48 years oldBMIthe overall prevalence of obesity among female university students in Iran was 3% (95% Cl 2.5%-3.6%) during 2001–2017. The highest prevalence of obesity was recorded in Tehran in 2005, 9.3% (95% Cl: 5.6%-15.1%) and the lowest prevalence of obesity was found in Ardebil in 2012, 1% (95% Cl: 0.4%-4%)12Fakhri et al., 2019 [36]931998 to 20173,845,768Children < 6 ≥ 6CDCIOTFIranian referenceCDC2000TSFWHOthe prevalence of obesity in Iranian children was 7% (girls 8% and boys 10%), and the prevalence of overweight was 12% (girls 17% and boys 15%). The incidence rate of obesity in children was 13% based on The US CDC 2000 reference, 11% on the IOTF reference, 9% on the WHO reference, 9% on Iranian reference, 5% on CDC reference, and 3% on the NCHS reference. Meta-regression diagram also showed that the prevalence of obesity in children was not dependent on sample size. However, the prevalence of obesity declined from 1999 to 2016, which was statistically significant13Mansori et al., 2019 [37]6January 1989 and August 20175,136children aged < 5 yearsNCHS/WHOthe prevalence of obesity and overweight were estimated to be 8% (95% confidence interval [CI], 6%–10%) and 9% (95% CI, 7%–11%), respectively. The results of the subgroup analysis showed that the prevalence of obesity in boys and girls was 9% (95% CI, 6%–13%) and 7% (95% CI, 4–10%), respectively, and the prevalence of overweight in boys and girls was 10% (95% CI, 5%–15%) and 9% (95% CI, 5%–13%), respectively14Salimi et al., 2019 [38]10up to December 201717,920Iranian military personnelWHOBMIThe pooled prevalence of overweight and obesity was 41% (95%CI:26, 57%) and 13% (95%CI:10, 17%), respectively. In the subgroup analyses, a lower and higher prevalence of overweight was reported in the ground (12%) and Navy (69%) forces military, respectively. For obesity, the Air Forces had the lowest prevalence (11%), and the ground and Navy forces military had the highest prevalence (15%). The prevalence of overweight and obesity was slightly higher in studies conducted after 201415Vaisi-Raygani et al., 2019 [39]18March 2000 to October 201829,943older adultsaged > 50 yearsBMI ≥ 30the prevalence of obesity in older adults of Iran was 21.4% (95%CI: 26.6–16.9%) based on the meta-analysis. The highest obesity prevalence was obtained in older adults of Babol (Amir Shahr) which was 44.2% (95%CI: 41.1–47.2%) in 2007, while the minimum obesity prevalence was found in older adults of Razavi Khorasan which was 11.3% (95%CI, 10–12.8%) in 2007. Further, as the sample size and the study year increased, the obesity prevalence diminished in older Iranian adults (p < 0.05)16Sarokhani et al., 2020 [40]1601977–2017481,070Iranian students6–20 yearsBMIThe prevalence of obesity among Iranian students based on body mass index (BMI) was 11% (95% confidence interval [CI]: 10%–12%) (in girls 8% [95% CI: 7%–10%] and in boys 11% [95% CI: 10%–13%]). The prevalence of overweight in students based on BMI was 12% (95% CI: 12%–13%) (in girls 13% [95% CI: 11%–14%] and in boys 11% [95% CI: 18%–30%]). The rate of obesity was 13% (95% CI: 11%–16%) in elementary school students, 10% (95% CI: 7%–14%) in secondary school students and 7% (95% CI: 6%–9%) in high school students17Hosseini et al., 2021 [41]52August 10, 2010 to August 10, 2020120,440Iranian men 20–70 yearsBMIThe pooled prevalence of overweight in men was 46% (95% CI: 46, 46). The lowest prevalence of overweight was 11.1% in Fars and the highest was 57% in Tabriz. The pooled prevalence of obesity in men was 18% (95% CI: 18, 19), with the highest prevalence in Birjand (46.5%) and the lowest in Tehran (0.8%)18Djalalinia et al., 2021 [42]432016471,500Iranian population25 – 85yBMIThe overall prevalence of obesity and overweight in males was 18.4% (16.9–20) and 57.1% (53.7- 60.6), and in females was 36.8% (34.1–39.7) and 71.7% (67.9–75.8), respectively19Akbari et al., 2022 [15]23January 2000 to January 20212,637,912Iranian Children aged 2–15 yearsNMThe overall prevalence of obesity in Iranian children was 11.4% (95% CI: 9.4–13.7%) based on a meta-analysis. Also, in order to investigate the effects of potential factors (sample size and year of study) on the heterogeneity of obesity prevalence in Iranian children, meta-regression was used. It was reported that the prevalence of obesity in Iranian children decreased and increased with increasing sample size and increasing years of the study, respectively,20Saeidi et al., 2022 [43]12up to February 202216,745Iranian Primary School Students6–14 yearsBMICDCIOTFThe prevalence of obesity and overweight in primary school children was 14.3% (3.1–14.3%), and 18.8% (5.5–18.8%), respectively. Obesity and overweight were more prevalent in primary students from Semnan and less prevalent in students from Tabriz. Based on the results, the relationship between overweight and obesity in students with their age, gender, weight at birth, school type, taking snacks, walking time to school, family size, parental education, father’s job, parental obesity, physical activity levels, and family income was significant21Shirzadeh et al., 2021 [7]12up to September 20219,012Iranian High School StudentsBMI indexCDC 2000IOTEThe prevalence of overweight and obesity in students was 20.5% (ranged: 2.3–20.5%), and 21% (ranged: 6.1–21%), respectively. The highest prevalence of overweight and obesity was observed in students in Urmia and Yazd, respectively. There was a significant relationship between obesity and overweight students and birth weight, formula or breastfeeding, time of starting solid foods, family income, family history of obesity, parents’ education, physical activity, time spent on TV and computer games, taking snacks, private school, and having rice during a week22Okati-Aliabad et al., 2022 [44]112000–2020257,555aged > 15 yearsBMIThe prevalence of obesity and overweight in Iran was estimated at 22.41 (19.32–25.99) and 33.92 (26.47–43.48), respectively23Abiri et al., 2023 [13]152January 2012 and December 20212,456,489 ≤ 18 years > 18 yearsCombination of age groupsBMIThe prevalence of overweight and obesity in Iran was estimated at 20.1 (95% CI 17.92–22.30) and 13.44 (95% CI 11.76–15.22), respectively. This percentage (95% CI) was 11.71 (10.98–12.46) for overweight and 8.08 (7.02–9.22) for obesity in those aged ≤ 18 years, and 35.26(32.61–37.99) for overweight and 21.38 (19.61–23.20) for obesity in those aged > 18 years. The overall prevalence of overweight and obesity in the entire population was 35.09% (95% CI 31.31–38.98)24Hojjati et al., 2023 [45]10Up to November 20226,831Iranian university studentsBMIthe overall GO prevalence in IUSs was detected 5.1% (95% CI:1.6–15.4), the overall OW prevalence was 17.7% (95% CI:12.5–24.5), The overall AO prevalence in IUSs was detected 12.5% (CI95% = 9.1–16.9). the highest OW prevalence was detected at 15% (95% CI:10.4–21.3) in male IUSs and the highest AO prevalence was reported at 11.4% (95% CI:6.2–20.2) in male IUSsNM Not mentioned, BMI Body mass index, P95 Percentile 95%, NCHS National Center for Health Statistics, IOTF International Obesity Task Force, CDC The Centers for Disease Control and Prevention, WHO World Health Organization, NHANES National Health and Nutrition Examination Survey, NCHS National Center for Health Statistic, CI confidence interval, GO General obesity, OW Overweight, AO Abdominal obesity, IUSs Iranian university students Characteristics of the included studies in Umbrella Systematic Review and Meta-Analysis of Obesity and Overweight Prevalence in Iranian Children and Adolescents (> 18 yr.), (< 18y) adults and children BMI > 30 BMI > P95 NCHS (BMI calculated by weight (kg)/height2 (m); P95; NCHS) The overall prevalence of obesity for adults (> 18 yr) and children (< 18y) was 21.5% (CI 95% 17.4–25.6) and 5.5% (CI 95% 4.5–6.4), respectively The prevalence of obesity in boys and girls (< 18y) was 5.3% (CI 95% 4.1–6.4) and 4.8% (CI 95% 4.0–5.7), respectively It increased in both adult men and women to 13.7% (CI 95% 10.9–16.7) and 27.3% (CI 95% 21.3–33.4), respectively adolescents and children < 20 > 20 aged 14—81 years Adolescents and adults CDC, WHO, and IOTF for children aged 5 or younger that include BMI-for-age growth charts defines obesity and overweight as > 95th, and 85-95th percentile of body mass index, respectively. The NCHS/WHO cut-off percentile classification for age includes: underweight < 5th BMI-for-age; normal weight 5th < BMI-for-age < 85th; overweight 85th BMI-for-age < 95th; and obese BMI-for-age > 95th. The same percentiles cut-offs were considered for the CDC as well. IOTF used data from six national studies carried out in different countries to provide percentile curves that passed through the widely used cut-off points of 25 kg/m2 and 30 kg/m2 for adults overweight and obesity The range of overweight and obesity prevalence in national studies in adults, was 27.0–38.5 (95% CI: 26.8–27.1, 37.2–39.8), and 12.6–25.9 (95% CI: 12.2–13.0, 24.9–26.8), separately. In < 18 the range of overweight and obesity prevalence in national studies was 5.0–13.5 (95% CI: 4.5–5.5, 13.4–13.6), and 3.2–11.9 (95% CI: 3.0–3.4, 11.3–12.4) U.S. CDC in 2000 (i.e., 85th percentile BMI _ 94th percentile was regarded as overweight and BMI _ 95th percentile as obese); WHO (i.e., BMI _ 2 z score was regarded as overweight and BMI _ 3 z score as obese); or IOTF (i.e., percentile curves that correspond to cutoff points of 25 kg/m2 and 30 kg/m2 for adult overweight and obesity, respectively) between 1990 and 2011 > 18 < 18 the WHO, was defined as BMI ≥ 30 for adult populations (at least 18 years of age). For people < 18, most articles used the criteria of the CDC 2000 and IOTF which defined obesity according to the BMI ≥ percentile 95th of the BMI in the respective population > 18 years and < 18 years CDC BMI > P95 IOTF the prevalence of obesity was 8.5% (95% confidence interval [CI], 7.9%-9%) overall, 5.5% (95% CI, 5.1%-6.0%) among < 18 years and 15.1% (95% CI, 13.8%-16.5%) among adult also the prevalence of overweight was 17.5% (95% confidence interval [CI], 15.9%-19.1%) overall, 15.1% (95% CI, 13.5%—17%) among < 18 years and 22.6% (95% CI, 19.5%—26.1%) among adult CDC BMI > P95 IOTF Hosseini’s Iranian children’s reference CDC IOTF Hosseini’s Iranian children’s reference Iranian female university students 15–48 years old Children < 6 ≥ 6 CDC IOTF Iranian reference CDC2000 TSF WHO WHO BMI older adults aged > 50 years Iranian students 6–20 years Iranian population 25 – 85y Iranian Primary School Students 6–14 years BMI CDC IOTF BMI index CDC 2000 IOTE ≤ 18 years > 18 years Combination of age groups The prevalence of overweight and obesity in Iran was estimated at 20.1 (95% CI 17.92–22.30) and 13.44 (95% CI 11.76–15.22), respectively. This percentage (95% CI) was 11.71 (10.98–12.46) for overweight and 8.08 (7.02–9.22) for obesity in those aged ≤ 18 years, and 35.26 (32.61–37.99) for overweight and 21.38 (19.61–23.20) for obesity in those aged > 18 years. The overall prevalence of overweight and obesity in the entire population was 35.09% (95% CI 31.31–38.98) NM Not mentioned, BMI Body mass index, P95 Percentile 95%, NCHS National Center for Health Statistics, IOTF International Obesity Task Force, CDC The Centers for Disease Control and Prevention, WHO World Health Organization, NHANES National Health and Nutrition Examination Survey, NCHS National Center for Health Statistic, CI confidence interval, GO General obesity, OW Overweight, AO Abdominal obesity, IUSs Iranian university students Methodological quality of included studies Table 3 displays the assessment outcomes of each study’s methodology using the AMSTAR2 tool [46]. Out of the total number of publications (n = 24), the majority were of intermediate quality, with four being of good quality and the remaining papers being of low quality. As a result, the overall quality was average. Similarly, when utilizing the GRADE and Credibility Assessment tool, all qualitative impacts were rated as moderate or poor and III or IV evidence class, respectively (Table 4). Table 3Results of assessment of the methodological quality of included meta-analysisStudyQ1Q2Q3Q4Q5Q6Q7Q8Q9Q10Q11Q12Q13Q14Q15Q16Quality assessmentMirzazadeh et al., 2009 [26]Partial YesPartial YesYesPartial YesYesYesPartial YesYesNoNoYesYesNoNoNoYesModerateNg et al., 2013 [27]Partial YesPartial YesYesYesNoNoNoYesNoYesNoNoNoNoNoYesLowMirzazadeh et al., 2013 [28]Partial YesPartial YesYesYesYesYesPartial YesYesNoNoYesNoNoYesNoYesModerateJafari-Adli et al., 2014 [8]Partial YesPartial YesYesYesNoNoPartial YesYesNoNoYesNoNoPartial YesNoYesLowKelishadi et al., 2014 [29]YesPartial YesYesYesNoNoPartial YesYesNoNoYesNoNoNoNoNoLowRahmani et al., 2014 [30]YesPartial YesYesYesYesYesPartial YesYesNoNoYesNoNoYesNoNoModerateGhanbari et al., 2016 [31]YesPartial YesYesYesYesYesPartial YesYesNoNoYesNoNoNoNoYesModerateFallahzadeh et al., 2017 [32]YesPartial YesYesYesYesYesPartial YesYesNoNoYesNoNoNoNoNoLowKhazaei et al., 2017 [33]YesPartial YesYesYesYesYesPartial YesYesNoNoYesNoNoYesNoNoModerateKhazaei et al., 2017 [34]YesPartial YesYesYesYesYesPartial YesYesNoNoYesYesYesYesYesYesHighMohammadi et al., 2018 [35]YesPartial YesYesPartial YesNoNoPartial YesYesYesNoYesYesYesYesYesYesHighFakhri et al., 2019 [36]YesPartial YesYesYesYesYesPartial YesYesYesNoYesNoNoYesNoYesModerateMansori et al., 2019 [37]YesPartial YesYesYesYesYesPartial YesYesYesNoYesYesNoPartial YesYesYesHighSalimi et al., 2019 [38]YesPartial YesYesYesYesYesPartial YesYesNoNoYesNoNoYesYesYesModerateVaisi-Raygani et al., 2019 [39]YesPartial YesYesYesYesYesNoYesNoNoYesNoNoYesYesYesModerateSarokhani et al., 2020 [40]YesYesYesYesYesYesNoYesYesNoYesYesNoYesNoYesModerateHosseini et al., 2021 [41]YesPartial YesYesYesYesYesPartial YesYesNoNoYesNoNoYesNoYesModerateDjalalinia et al., 2021 [42]YesPartial YesNoYesYesYesNoYesNoNoYesNoNoNoNoYesLowAkbari et al., 2022 [15]YesPartial YesYesYesYesYesPartial YesYesNoNoYesNoNoYesYesYesModerateSaeidi et al., 2022 [43]YesPartial YesYesYesYesYesNoYesYesNoNoNoYesNoNoPartial YesModerateShirzadeh et al., 2021 [7]YesPartial YesYesYesYesYesNoYesYesNoNoNoYesNoNoPartial YesModerateOkati-Aliabad et al., 2022 [44]YesPartial YesYesPartial YesYesYesPartial YesYesNoNoYesNoNoYesNoPartial YesModerateAbiri et al., 2023 [13]YesPartial YesPartial YesYesYesYesNoYesNoNoYesNoNoYesNoYesModerateHojjati et al., 2023 [45]YesPartial YesPartial YesYesYesYesNoYesYesNoYesYesYesYesYesYesHigh1. Did the research questions and inclusion criteria for the review include the components of PICO? 2. Did the report of the review contain an explicit statement that the review methods were established prior to the conduct of the review and did the report justify any significant deviations from the protocol? 3. Did the review authors explain their selection of the study designs for inclusion in the review? 4. Did the review authors use a comprehensive literature search strategy? 5. Did the review authors perform study selection in duplicate? 6. Did the review authors perform data extraction in duplicate? 7. Did the review authors provide a list of excluded studies and justify the exclusions? 8. Did the review authors describe the included studies in adequate detail? 9. Did the review authors use a satisfactory technique for assessing the risk of bias (RoB) in individual studies that were included in the review? 10. Did the review authors report on the sources of funding for the studies included in the review? 11. If meta-analysis was performed, did the review authors use appropriate methods for statistical combination of results? 12. If meta-analysis was performed, did the review authors assess the potential impact of RoB in individual studies on the results of the meta-analysis or other evidence synthesis? 13. Did the review authors account for RoB in individual studies when interpreting/ discussing the results of the review? 14. Did the review authors provide a satisfactory explanation for, and discussion of, any heterogeneity observed in the results of the review? 15. If they performed quantitative synthesis, did the review authors carry out an adequate investigation of publication bias (small study bias) and discuss its likely impact on the results of the review? 16. Did the review authors report any potential sources of conflict of interest, including any funding they received for conducting the review?, Each question was answered with “Yes”, “Partial Yes” or “No”. When no meta-analysis was done, question 11, 12 and 15 were answered with “No meta-analysis conducted. Studies with ≥ 13 “yes” answers were categorized as “high”, 9–12 “yes” answers as “moderate”, 5–8 “yes” answers as “low”, and ≤ 4 “yes” answers as “critically low” Results of assessment of the methodological quality of included meta-analysis 1. Did the research questions and inclusion criteria for the review include the components of PICO? 2. Did the report of the review contain an explicit statement that the review methods were established prior to the conduct of the review and did the report justify any significant deviations from the protocol? 3. Did the review authors explain their selection of the study designs for inclusion in the review? 4. Did the review authors use a comprehensive literature search strategy? 5. Did the review authors perform study selection in duplicate? 6. Did the review authors perform data extraction in duplicate? 7. Did the review authors provide a list of excluded studies and justify the exclusions? 8. Did the review authors describe the included studies in adequate detail? 9. Did the review authors use a satisfactory technique for assessing the risk of bias (RoB) in individual studies that were included in the review? 10. Did the review authors report on the sources of funding for the studies included in the review? 11. If meta-analysis was performed, did the review authors use appropriate methods for statistical combination of results? 12. If meta-analysis was performed, did the review authors assess the potential impact of RoB in individual studies on the results of the meta-analysis or other evidence synthesis? 13. Did the review authors account for RoB in individual studies when interpreting/ discussing the results of the review? 14. Did the review authors provide a satisfactory explanation for, and discussion of, any heterogeneity observed in the results of the review? 15. If they performed quantitative synthesis, did the review authors carry out an adequate investigation of publication bias (small study bias) and discuss its likely impact on the results of the review? 16. Did the review authors report any potential sources of conflict of interest, including any funding they received for conducting the review?, Each question was answered with “Yes”, “Partial Yes” or “No”. When no meta-analysis was done, question 11, 12 and 15 were answered with “No meta-analysis conducted. Studies with ≥ 13 “yes” answers were categorized as “high”, 9–12 “yes” answers as “moderate”, 5–8 “yes” answers as “low”, and ≤ 4 “yes” answers as “critically low” Table 4Summary of results and quality of evidence assessment using the GRADE and Credibility Assessment approachOutcome measuresSummary of findingsQuality of evidence assessment (GRADE)Credibility AssessmentNo. of patients*/ number of meta-analyses (included studies)Effect size (95% CI)Risk of biasaInconsistencybIndirectnesscImprecisiondPublication biaseQuality ofevidencefEvidence classgOverall prevalence of overweight11,204,070/1418.38% (10.267, 26.496)Not seriousseriousNot seriousNot seriousNot seriousModerateIIIOverall prevalence of obesity14,345,043/1510.91% (9.654, 12.177)Not seriousseriousNot seriousNot seriousseriousLowIIIPrevalence overweight among children and adolescents8,255,303/1012.43% (10.184, 14.683)Not seriousseriousNot seriousNot seriousseriousLowIIIPrevalence of obesity among children and adolescents11,143,533/146.51% (5.866, 7.157)Not seriousseriousNot seriousNot seriousseriousLowIIIPrevalence of overweight among adults4,338,046/827.39% (14.878, 39.914)Not seriousseriousNot seriousNot seriousNot seriousModerateIIIPrevalence of obesity among adults868,685/1217.20% (13.483, 20.919)Not seriousseriousNot seriousNot seriousNot seriousModerateIV*By considering overlap among the studiesaRisk of bias based on the AMSTAR resultsbDowngraded if there was a substantial unexplained heterogeneity (I2 > 50%, P < 0.10) that was unexplained by meta-regression or subgroup analysescDowngraded if there were factors present relating to the participants, interventions, or outcomes that limited the generalizability of the resultsdDowngraded if optimal information size was not met, or the 95%CI include the null value lower and upper bounds of the 95%CI were < 0.95 and > 1.05, respectivelyeDowngraded if there was an evidence of publication bias using funnel plotfSince all included studies were meta-analyses, the certainty of the evidence was graded as high for all outcomes by default and then downgraded based on prespecified criteria. Quality was graded as high, moderate, low, very lowg Class I: (convincing evidence), > 1000 cases (or > 20 000 participants for continuous outcomes); statistical significance at P < 10−6 (random effects); no evidence of small study effects and excess significance bias; 95% prediction interval excluded null value; no large heterogeneity (I2 < 50%)Class II: (highly suggestive evidence), > 1000 cases (or > 20 000 participants for continuous outcomes), statistical significance at P < 10−6 (random effects), and largest study with 95% confidence interval excluding null valueClass III: (suggestive evidence), > 1000 cases (or > 20 000 participants for continuous outcomes) and statistical significance at P < 0.001Class IV: (weak evidence), Remaining significant associations with P < 0.05NS: non-significant, P > 0.05 Summary of results and quality of evidence assessment using the GRADE and Credibility Assessment approach *By considering overlap among the studies aRisk of bias based on the AMSTAR results bDowngraded if there was a substantial unexplained heterogeneity (I2 > 50%, P < 0.10) that was unexplained by meta-regression or subgroup analyses cDowngraded if there were factors present relating to the participants, interventions, or outcomes that limited the generalizability of the results dDowngraded if optimal information size was not met, or the 95%CI include the null value lower and upper bounds of the 95%CI were < 0.95 and > 1.05, respectively eDowngraded if there was an evidence of publication bias using funnel plot fSince all included studies were meta-analyses, the certainty of the evidence was graded as high for all outcomes by default and then downgraded based on prespecified criteria. Quality was graded as high, moderate, low, very low g Class I: (convincing evidence), > 1000 cases (or > 20 000 participants for continuous outcomes); statistical significance at P < 10−6 (random effects); no evidence of small study effects and excess significance bias; 95% prediction interval excluded null value; no large heterogeneity (I2 < 50%) Class II: (highly suggestive evidence), > 1000 cases (or > 20 000 participants for continuous outcomes), statistical significance at P < 10−6 (random effects), and largest study with 95% confidence interval excluding null value Class III: (suggestive evidence), > 1000 cases (or > 20 000 participants for continuous outcomes) and statistical significance at P < 0.001 Class IV: (weak evidence), Remaining significant associations with P < 0.05 NS: non-significant, P > 0.05 The overall prevalence of overweight and obesity The results of 14 meta-analyses comprising 22 Effect Sizes (ESs) indicated that the prevalence of overall overweight among the Iranian population was 18.38% (95% CI: 10.267, 26.496) (Fig. 2), with significantly high heterogeneity among the studies (I2 = 100%, p < 0.001). Sub-group analysis revealed that the prevalence of overweight was higher in the meta-analyses, which included ≥ 50 studies (ES = 20.48%, 95% CI: 6.053, 34.923) and collected data after 2015 (ES = 26.12%, 95% CI: 9.615, 42.627). There wasn’t a significant publication bias based on Egger’s test (p = 0.716), and the funnel plot also approves this result (Suppl. Figure 1). Forest plot detailing effect sizes and 95% confidence intervals (CIs) of the overall prevalence of overweight among the Iranian population The results of combining 34 ESs of 21 meta-analyses demonstrated that the overall prevalence of obesity was 10.91% (95% CI: 9.654, 12.177) (Fig. 3). There was a high heterogeneity among the studies (I2 = 99.2%, p < 0.001). The overall obesity prevalence in males was 9.93 (95% CI: 8.483, 11.388), and in females was 9.67% (95% CI: 8.317, 11.033). According to subgroup analysis (Table 5), the prevalence of obesity was higher in studies that collected data after 2015 (ES = 13.778%, 95% CI: 9.803, 17.753), with a high heterogenicity (I2 = 99.4%, p = 0.000) among the studies. The Egger’s tests indicated a small study effect (p = 0.001), and an asymmetry was also observed in the funnel plot. The Trim-and-fill method didn’t change this result (Suppl. Figure 2). Forest plot of the overall prevalence of obesity among the Iranian population Table 5Subgroup analyses for the prevalence of overweight and obesity among Iranian populationEffect size (n)ES (95% CI)aP-within bI2 (%) cP-heterogeneitydOverall obesity Included study number < 502111.144 (9.888, 12.401)0.00097.30.000 ≥ 501311.651 (8.814, 14.487)0.00099.50.000 Year of data collection ≤ 2015218.390 (7.487, 9.293)0.00098.00.000 > 20151313.778 (9.803, 17.753)0.00099.40.000 Gender Male229.936 (8.483, 11.388)0.00097.60.000 Female229.675 (8.317, 11.033)0.0000.000Adults Included study number < 501317.079 (11.424, 22.733)0.00098.40.000 ≥ 50517.598 (11.548, 23.648)0.00099.40.000 Year of data collection ≤ 20151018.465 (14.007, 22.923)0.00096.80.000 > 2015815.562 (8.406, 22.718)0.00099.60.000 Gender Male812.722 (10.105, 15.339)0.00092.90.000 Female918.632 (11.752, 25.513)0.00099.30.000Children and adolescent Included study number < 50135.918 (5.253, 6.584)0.00094.20.000 ≥ 5086.970 (5.714, 8.226)0.00096.10.000 Year of data collection ≤ 2015155.423 (4.939, 5.907)0.00093.20.000 > 2015610.484 (8.323, 12.645)0.00092.80.000 Gender Male158.485 (7.207, 9.762)0.00096.70.000 Female155.928 (5.053, 6.803)0.00096.40.000Overall overweight Included study number < 501314.657 (11.861, 17.453)0.00099.40.000 ≥ 50920.488 (6.053, 34.923)0.0051000.000 Year of data collection ≤ 20151413.835 (11.273, 16.397)0.00099.50.000 > 2015826.121 (9.615, 42.627)0.0021000.000 Gender Male1415.792 (12.949, 18.634)0.00098.60.000 Female1317.579 (14.714, 20.444)0.00099.20.000Adults Included study number < 50624.654 (19.630, 29.679)0.00076.50.001 ≥ 50528.707 (9.608, 47.806)0.00399.90.000 Year of data collection ≤ 2015621.201 (15.719, 26.682)0.00096.70.000 > 2015534.616 (24.891, 44.341)0.00097.40.000Children and adolescent Included study number < 501112.509 (9.669, 15.348)0.00099.50.000 ≥ 50612.415 (11.133, 13.697)0.00092.00.000 Year of data collection ≤ 20151311.864 (9.343, 14.384)0.00099.50.000 > 2015412.196 (11.134, 13.258)0.04662.50.000ES Effect size, CI confidence intervalaObtained from the Random-effects modelbRefers to the mean (95% CI)cInconsistency, percentage of variation across studies due to heterogeneitydObtained from the Q-test Subgroup analyses for the prevalence of overweight and obesity among Iranian population ES Effect size, CI confidence interval aObtained from the Random-effects model bRefers to the mean (95% CI) cInconsistency, percentage of variation across studies due to heterogeneity dObtained from the Q-test Prevalence of overweight and obesity among children and adolescents The pooled results of 10 meta-analyses, including 17 ESs, demonstrated that the prevalence of overweight among children and adolescents was 12.43% (95% CI: 10.184, 14.683) (Fig. 4). There was considerable heterogeneity among the studies (I2 = 99.5%, p = 0.000). The prevalence of overweight in males (ES = 15.792, 95% CI: 12.949, 18.634) was higher than in females (ES = 17.57%, 95% CI: 14.714, 20.444), with a high heterogeneity among the studies. Based on the sub-group test, the prevalence of overweight was higher in the studies that collected data after 2015 (ES = 12.19%, 95% CI: 11.134, 13.258) with a relatively high heterogenicity (I2 = 62.5%, p = 0.046) among the studies. Egger’s tests indicated a publication bias (p = 0.005), and the funnel plot also showed an asymmetry to the right. The trim-and-fill technique was used in 19 studies, and two imputed ESs reduced the overweight prevalence (ES = 11.83%, 95% CI: 10.035, 13.636) and the asymmetry of the funnel plot (Suppl. Figure 3). Forest plot of the prevalence of overweight among children and adolescents Combining the findings of 14 meta-analyses comprising 21 ESs indicated that the prevalence of obesity among Iranian children and adolescents was 6.51% (95% CI: 5.866, 7.157) with high heterogeneity (I2 = 96.5%, p = 0.000) among the studies (Fig. 5). The prevalence of obesity in males was higher (ES = 8.48%, 95% CI: 7.207, 9.762) than in females (ES = 5.92%, 95% CI, 5.053, 6.803). Moreover, sub-group analysis based on the year of data collection revealed that the prevalence of obesity was higher in the studies that collected data after 2015 (ES = 10.48%, 95% CI: 8.323, 12.645), with high heterogeneity (I2 = 92.8%, p = 0.000) among the studies. There is a significant publication bias based on Egger’s tests (p = 0.000), and an asymmetry was also observed to the right of the funnel plot. The trim-and-fill method did not change the results (Suppl. Figure 4). Forest plot of the prevalence of obesity among Iranian children and adolescents Prevalence of overweight and obesity among adults The combined 11 ESs of 8 meta-analyses demonstrated that the prevalence of overweight was 27.39% (95% CI: 14.878, 39.914) among Iranian adults (Fig. 6), with considerable heterogeneity among the studies (I2 = 99.8%, p = 0.000). Upon sub-group analyses, the prevalence of overweight was higher in the meta-analyses that included ≥ 50 studies (ES = 28.70%, 95% CI: 9.608, 47.806), and their data collection year was after 2015 (ES = 34.61%, 95% CI: 24.891, 44.341). There wasn’t a significant publication bias based on the results of Egger’s test (p = 0.079). However, there was an asymmetry to the left of the funnel plot that, by the trim-and-fill method, this result didn’t change (Suppl. Figure 5). Forest plot of the prevalence of overweight among Iranian adults The pooled results of 12 meta-analyses comprising 18 ESs displayed that the prevalence of obesity among adults was 17.20% (95% CI: 13.483, 20.919) (Fig. 7). There was significant heterogeneity among the studies (I2 = 99.2%, p = 0.000). The prevalence of obesity among male adults was lower (ES = 12.72%, 95% CI: 10.105, 15.339) than in females (ES = 18.632, 95% CI: 11.752, 25.513). According to subgroup analysis, the prevalence of obesity in the studies with a year of data collection ≤ 2015 (ES = 18.465%, 95% CI: 14.007, 22.923) was higher than above 2015 with a high heterogenicity (I2 = 96.8%, p = 0.000) (Table 5). The Egger’s tests indicated no small study effect among the studies (p = 0.189). However, there was an asymmetry to the right of the funnel plot. As a result, the trim-and-fill method was applied with 21 ESs (three imputed), which decreased the prevalence of obesity among adults [ES: 15.571, 95% CI (12.288, 18.854)] (Suppl. Figure 6). Forest plot of the prevalence of obesity among adults Discussion The overall prevalence of overweight and obesity among the Iranian population was 18.38% and 10.91%, respectively. The overall obesity prevalence was 9.93% in males and 9.67% in females. The prevalence of overweight and obesity among children and adolescents was 12.43% and 6.51%, and in adults, it was 27.39% and 17.20%, respectively. Male children and adolescents had a higher prevalence of overweight and obesity than females, but male adults had a lower prevalence of obesity than females. The STEPs survey in 2011 demonstrated that, in total, 22.3% of Iranian adults aged ≥ 15 years were obese, with 14% being males and 27.7% being females [47]. In 2014, the age-standardized prevalence of obesity in Iran was estimated at 10.8% in males and 14.9% in females [1]. In 2016, the national prevalence rates of obesity and overweight/obesity among Iranian adults were 22.7% (22.2–23.2) and 59.3% (58.7–59.9), respectively. Childhood obesity will continue into adulthood, and studies have proven that more than 69% of children aged 6 to 10 are obese in adulthood. According to the published reports of the WHO and the National Health and Nutrition Examination Survey (NHANES) IV, about 16% and 30% of children are overweight or at risk of being overweight, respectively [48, 49]. The WHO Regional Office for Europe established the Childhood Obesity Surveillance Initiative (COSI) to observe changes in overweight and obesity in school-aged children in 2007 [11, 50]. The prevalence of childhood obesity in the oldest study was 11.7% in the UK, 16.9% in the United States, 11.3% in China, 1.4% in Greece, 1.6% in Turkey, 13.7% in the United Arab Emirates (UAE), and 1% in Indian children [51–57]. In other studies, this prevalence in Cyprus was 8.1%, in North Korea it was 9.7%, and in Spain it was 8.5% [58–60]. Body weight is influenced by a multifaceted and interrelated combination of factors, including biological factors (such as psychological factors, hormones, genetics, and epigenetics), social factors (such as education, employment status, income, and access to healthcare), food industry factors (such as food marketing and lobbying), access to physical activity opportunities, and various other factors [61, 62]. It seems that one of the causes of the prevalence and risk of overweight and obesity, especially in childhood, is the increase in social welfare and the industrialization of countries [63]. Growing urbanization and globalization may also induce a shift in the overweight and obesity trend because many kids and teenagers grow up in settings that promote weight gain and obesity. For example, today, people are exposed to cheap and easily available highly processed foods, which are often energy-dense and nutrient-poor [64, 65]. In addition, another reason is that opportunities for physical activity, especially active transportation, may have decreased in recent decades. A school-based study in 146 countries found that insufficient physical activity decreased among adolescent boys but showed no change among adolescent girls [66–68]. In the meantime, the use and exposure of today’s generation to sedentary behaviors such as watching TV, long-term use of electronic devices, etc., have increased. The alteration in food type, excessive portions, availability, and reduction in active transportation would have caused an energy imbalance [67, 69]. Lifestyle changes, especially dietary habits, insufficient physical activity, and increasing digital technology, lead to an increasing prevalence of obesity in rural and urban environments. Some ethnic factors, such as genetics, socioeconomic status, and dietary patterns, can also contribute to obesity [8, 70, 71]. A sedentary life and increased consumption of inappropriate high-calorie foods are the most obvious causes of obesity [72]. On the other hand, the COVID-19 pandemic led to people being confined to their homes, and there was a ban on participating in sports or social activities. However, the pandemic resulted in a decrease in physical activity and an increase in the intake of unhealthy food, leading to a rise in sedentary behavior and higher levels of anxiety. Consequently, there has been an increase in overweight and obesity rates [73–77]. A study on 43,660 Iranian students showed that during the COVID-19 epidemic, half of the participants were overweight, and most did not have regular physical activity during the pandemic [78]. A systematic review study showed that children watch television for between 1.5 and 3.5 h per day. Exposure to television food advertisements is associated with weight gain and obesity [79]. It has also been shown that in Iran, family history of obesity, early marriage, parity, old age, low physical activity, and education are factors of obesity, especially central obesity in the urban population [80]. Socioeconomic factors also have a significant effect on weight, especially in teenagers. One possible explanation for this phenomenon is that in populations with a low socioeconomic status, the diet primarily consists of a high intake of carbohydrates, which are more readily accessible in their surroundings [81]. In addition, lack of sleep and sleep disorders may lead to hormonal changes, unhealthy eating patterns such as increased consumption of foods with a high glycemic index, and reduced physical activity [81, 82]. The prevalence of obesity and overweight is increasing in Iran, causing health and socioeconomic problems. Studying obesity and overweight and having access to comprehensive and accurate data on this issue is necessary to assess public health, determine appropriate and relevant health policies, and design and implement preventive measures against obesity. Strengths and limitations Considering the need to collect evidence on the prevalence of obesity and overweight in developing countries, which is needed for evidence-based policy making, and the lack of information and large-scale cohort studies in these countries, this umbrella systematic review was designed for Iran in order to obtain a comprehensive summary from the existing studies. This umbrella systematic review and meta-analysis investigated obesity and overweight prevalence in children, adolescents, and adults of both genders. Focusing the current study on Iran can be considered a limitation. The current study protocol was not registered in Prospero. Moreover, the cross-sectional designs of every meta-analysis in our study limited our review because of their observational nature. This is because cross-sectional observational studies cannot describe the cause-and-effect relationship. Also, the number of studies in different geographical regions of Iran was very small. Also, studies to investigate the prevalence of obesity in special conditions, such as pregnancy, are limited. The weight of studies included multiple times in distinct meta-analyses was increased due to the overlap of some studies among meta-analyses. This was one of our umbrella meta-analysis’s major and unavoidable limitations, which may affect the overall result and confound the findings. Any interpretation should consider this limitation since we could not completely rule out the impact of various original study inclusions. The high heterogeneity of our results can be acknowledged as a limitation for their interpretation, too. Conclusion This survey is the first of its kind in the Middle East, and it shows that the increasing trend of obesity and overweight among Iranians is alarming. Due to the growing prevalence of obesity and overweight in the Iranian population, health policymakers should plan in the field of education and also take effective measures in terms of periodic screening. This study, which calculates and combines the results of all studies, provides research evidence about the trend of obesity and overweight among the Iranian population. Since the increasing trend of overweight and obesity is alarming, these studies are necessary to provide information to policymakers and healthcare providers at the national and regional levels so that preventive programs and interventions can be designed and performed. Supplementary Information Supplementary Material 1 Supplementary Material 2 Supplementary Material 3 Supplementary Material 4 Supplementary Material 5 Supplementary Material 6 Supplementary Material 7 Supplementary Material 8 Supplementary Material 9 Authors’ contributions A.D. and R.MG. conducted the search and data extraction, and A.D. and MMN screened the studies. A.D., MH.A., and SM.TJ. drafted the manuscript; A.N., A.P., F.S. and F.MN commented on subsequent revisions. All authors read and approved the final content. Funding This study has no funding. Data availability Data is provided within the manuscript or supplementary information files. Declarations Ethics approval and consent to participate This study was approved by Research Vice Chancellery of Iran University of Medical Sciences, Tehran, Iran (Ethics Code: IR.IUMS.REC.1402.769). As the present study is an umbrella systematic review and meta-analysis, the consent to participate is not applicable. Consent for publication Not applicable. Competing interests The authors declare no competing interests. Footnotes Publisher’s Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. References Associated Data Supplementary Materials Supplementary Material 1 Supplementary Material 2 Supplementary Material 3 Supplementary Material 4 Supplementary Material 5 Supplementary Material 6 Supplementary Material 7 Supplementary Material 8 Supplementary Material 9 Data Availability Statement Data is provided within the manuscript or supplementary information files.